ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
118.20
-2.37 (-1.96%)
At close: Aug 20, 2026, 4:00 PM EDT
118.62
+0.43 (0.36%)
Pre-market: Aug 21, 2026, 8:27 AM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $10.95 billion as of August 21, 2026. Its market cap has increased by 111.11% in one year.
Market Cap
10.95B
Enterprise Value
10.42B
1-Year Change
111.11%
Ranking
Category
Stock Price
$118.20
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $10.95B, an increase of 4,756.20%. That is a compound annual growth rate of 41.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 10.95B | -0.48% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 11.43B |
| Bio-Techne | 11.29B |
| Cytokinetics | 10.81B |
| Praxis Precision Medicines | 10.78B |
| Kymera Therapeutics | 10.59B |
| Summit Therapeutics | 10.46B |
| Krystal Biotech | 10.16B |
| Apogee Therapeutics | 10.16B |